View EO 12866 Meeting 0910-AI31

  Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

  0910-HHS/FDA

  Proposed Rule Stage

  09/28/2023 11:30 AM

  Outsourcing Facilities Association   Marc Wagner


 
List of Documents
OFA _RIN 0910-AI31
 
List of Attendees Participation
•   Jean McCue  - FDA Teleconference 
•   Julie Wise  - OMB Teleconference 
•   Joanne Davenport  - OMB Teleconference 
•   Elizabeth Ashley  - OMB Teleconference 
•   Jane Wargo  - HHS Teleconference 
•   Kathleen Anderson  - FDA Teleconference 
•   Aaron Young  - FDA Teleconference 
•   Emily Galloway  - FDA Teleconference 
•   Gabrielle Cosel  - FDA Teleconference 
•   Nnaemeka Chukwudebe  - FDA Teleconference 
•   Nicholas Beshara  - FDA Teleconference 
•   Ian Reynolds  - FDA Teleconference 
•   Marc Wagner  - Outsourcing Facilities Association In Person 
•   Adam Higgins  - BakerHostetler (on behalf of Outsourcing Facilities Association) In Person 
•   Lee Rosebush  - Outsourcing Facilities Association In Person